参考文献/References:
[1]Sung H,Ferlay J,Siegel RL,et al.Global Cancer Statistics 2020:GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J].CA Cancer J Clin,2021,71(3):209-249.[2]Li S,Liao Y,Ho M,et al.miRNA arm selection and isomiR distribution in gastric cancer[J].BMC Genomics,2012,13(Suppl 1):S13.[3]Nakamura M,Hayashi M,Konishi H,et al.MicroRNA-22 enhances radiosensitivity in cervical cancer cell lines via direct inhibition of c-Myc binding protein, and the subsequent reduction in hTERT expression[J].Oncol Lett,2020,19(3):2213-2222.[4]Konishi H,Hayashi M,Taniguchi K,et al.The therapeutic potential of exosomal miR-22 for cervical cancer radiotherapy[J].Cancer Biol Ther,2020,21(12):1128-1135.[5]Zhang L,Chen B,Ding D.Decreased microRNA-22 is associated with poor prognosis in cervical cancer[J].Int J Clin Exp Pathol,2017,10(9):9515-9520.[6]Wei W,Liu C.Prognostic and predictive roles of microRNA411 and its target STK17A in evaluating radiotherapy efficacy and their effects on cell migration and invasion via the p53 signaling pathway in cervical cancer[J].Mol Med Rep,2020,21(1):267-281.[7]Shan D,Shang Y,Hu T.MicroRNA-411 Inhibits Cervical Cancer Progression by Directly Targeting STAT3[J].Oncol Res,2019,27(3):349-358.[8]Jia L,Huang YP,Zheng YF,et al.miR-29b suppresses proliferation, migration, and invasion of tongue squamous cell carcinoma through PTEN-AKT signaling pathway by targeting Sp1[J].Oral Oncol,2014,50(11):1062-1071.[9]Zhang T,Xue X,Peng H.Therapeutic Delivery of miR-29b Enhances Radiosensitivity in Cervical Cancer[J].Mol Ther,2019,27(6):1183-1194.[10]Li Y,Zhang Z,Xiao Z,et al.Chemotherapy-mediated miR-29b expression inhibits the invasion and angiogenesis of cervical cancer[J].Oncotarget,2017,8(9):14655-14665.[11]Han Li C,Chen Y.Small and Long Non-Coding RNAs:Novel Targets in Perspective Cancer Therapy[J].Curr Genomics,2015,16(5):319-326.[12]Do D,Bozdag S.Cancerin:A computational pipeline to infer cancer-associated ceRNA interaction networks[J].PLoS Comput Biol,2018,14(7):e1006318.[13]Zhang H,Lu W.LncRNA SNHG12 regulates gastric cancer progression by acting as a molecular sponge of miR-320[J].Mol Med Rep,2018,17(2):2743-2749.[14]Wang C,Shao S,Deng L,et al.LncRNA SNHG12 regulates the radiosensitivity of cervical cancer through the miR-148a/CDK1 pathway[J].Cancer Cell International,2020,20(1):554.[15]Dong J,Wang Q,Li L.Upregulation of Long Non-Coding RNA Small Nucleolar RNA Host Gene 12 Contributes to Cell Growth and Invasion in Cervical Cancer by Acting as a Sponge for MiR-424-5p[J].Cell Physiol Biochem,2018,45(5):2086-2094.[16]Prensner J,Iyer M,Balbin O,et al.Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression[J].Nat Biotechnol,2011,29(8):742-749.[17]Huang L,Wang Y,Chen J,et al.Long noncoding RNA PCAT1,a novel serum-based biomarker, enhances cell growth by sponging miR-326 in oesophageal squamous cell carcinoma[J].Cell Death Dis,2019,10(7):513.[18]Ge X,Gu Y,Li D,et al.Knockdown of lncRNA PCAT1 Enhances Radiosensitivity of Cervical Cancer by Regulating miR-128/GOLM1 Axis[J].Onco Targets Ther,2020,13:10373-10385.[19]Dawson MA,Kouzarides T.Cancer epigenetics:from mechanism to therapy[J].Cell,2012,150(1):12-27.[20]Karakashev S,Zhu H,Yokoyama Y,et al.BET Bromodomain Inhibition Synergizes with PARP Inhibitor in Epithelial Ovarian Cancer[J].Cell Reports,2017,21(12):3398-3405.[21]Harkenrider MM,Markham MJ,Dizon DS,et al.Moving Forward in Cervical Cancer: Enhancing Susceptibility to DNA Repair Inhibition and Damage, an NCI Clinical Trials Planning Meeting Report[J].J Natl Cancer Inst,2020,112(11):1081-1088.[22]Ni M,Li J,Zhao H,et al.BRD4 inhibition sensitizes cervical cancer to radiotherapy by attenuating DNA repair[J].Oncogene,2021,40(15):2711-2724.[23]Stenmark H.Rab GTPases as coordinators of vesicle traffic[J].Nat Rev Mol Cell Biol,2009,10(8):513-525.[24]Tzeng HT,Wang YC.Rab-mediated vesicle trafficking in cancer[J].J Biomed Sci,2016,23(1):70.[25]Huang Y,Tian Y,Zhang W,et al.Rab12 Promotes Radioresistance of HPV-Positive Cervical Cancer Cells by Increasing G2/M Arrest[J].Front Oncol,2021,11:586771.[26]Kim J,Guermah M,Roeder RG.The human PAF1 complex acts in chromatin transcription elongation both independently and cooperatively with SII/TFIIS[J].Cell,2010,140(4):491-503.[27]Karmakar S,Dey P,Vaz AP,et al.PD2/PAF1 at the Crossroads of the Cancer Network[J].Cancer Res,2018,78(2):313-319.[28]Zheng JJ,He Y,Liu Y,et al.Novel role of PAF1 in attenuating radiosensitivity in cervical cancer by inhibiting IER5 transcription[J].Radiat Oncol,2020,15(1):131.[29]Lei H,Shi J,Teng Y,et al.Baicalein modulates the radiosensitivity of cervical cancer cells in vitro via miR-183 and the JAK2/STAT3 signaling pathway[J].Adv Clin Exp Med,2021.[30]殷书敏,徐振晔,邓海滨,等.中医药重塑肿瘤微环境的作用机制与优势[J].上海中医药大学学报,2019,33(5):1-7.[31]Liu C,Lin Q,Yun ZJR.Cellular and molecular mechanisms underlying oxygen-dependent radiosensitivity[J].Radiation Research,2015,183(5):487-496.[32]Hong BJ,Kim J,Jeong H,et al.Tumor hypoxia and reoxygenation:the yin and yang for radiotherapy[J].Radiat Oncol J,2016,34(4):239-249.[33]Dong D,Fu Y,Chen F,et al.Hyperoxia sensitizes hypoxic HeLa cells to ionizing radiation by downregulating HIF1alpha and VEGF expression[J].Mol Med Rep,2021,23(1):62.[34]Wisdom AJ,Hong CS,Lin AJ,et al.Neutrophils promote tumor resistance to radiation therapy[J].Proc Natl Acad Sci U S A,2019,116(37):18584-18589.[35]Khoshgard K,Hashemi B,Arbabi A,et al.Radiosensitization effect of folate-conjugated gold nanoparticles on HeLa cancer cells under orthovoltage superficial radiotherapy techniques[J].Phys Med Biol,2014,59(9):2249-2263.[36]Arians N,Nicolay NH,Brons S,et al.Carbon-ion irradiation overcomes HPV-integration/E2 gene-disruption induced radioresistance of cervical keratinocytes[J].J Radiat Res,2019,60(5):564-572.
相似文献/References:
[1]廖加群,曹 雪,陈燕平,等.宫颈癌盆腔淋巴结转移分布及危险因素分析[J].医学信息,2018,31(03):25.[doi:10.3969/j.issn.1006-1959.2018.03.008]
LIAO Jia-qun,CAO Xue,CHEN Yan-ping,et al.Distribution and Risk Factors of Pelvic Lymph Node Metastasis in Cervical Cancer[J].Medical Information,2018,31(09):25.[doi:10.3969/j.issn.1006-1959.2018.03.008]
[2]徐 洁.宫颈癌筛查及预防的研究进展[J].医学信息,2018,31(09):70.[doi:10.3969/j.issn.1006-1959.2018.09.022]
XU Jie.Advances in Screening and Prevention of Cervical Cancer[J].Medical Information,2018,31(09):70.[doi:10.3969/j.issn.1006-1959.2018.09.022]
[3]车 莹.HPV感染与宫颈病变相关性的研究[J].医学信息,2022,35(09):84.[doi:10.3969/j.issn.1006-1959.2022.09.021]
CHE Ying.Study on the Correlation Between HPV Infection and Cervical Lesions[J].Medical Information,2022,35(09):84.[doi:10.3969/j.issn.1006-1959.2022.09.021]
[4]曹 亮,郝 朋,李阳明,等.宫颈癌所致输尿管梗阻患者输尿管支架置入成功率影响因素的Meta分析[J].医学信息,2022,35(09):124.[doi:10.3969/j.issn.1006-1959.2022.09.031]
CAO Liang,HAO Peng,LI Yang-ming,et al.Meta Analysis of Factors Influencing Success Rate of Ureteral Stent Implantation in Patients with Ureteral Obstruction Caused by Cervical Cancer[J].Medical Information,2022,35(09):124.[doi:10.3969/j.issn.1006-1959.2022.09.031]
[5]覃念群,刘 楷,米镜霖,等.基于生物信息学分析筛选与宫颈癌预后相关的关键基因[J].医学信息,2022,35(10):8.[doi:10.3969/j.issn.1006-1959.2022.10.002]
QIN Nian-qun,LIU Kai,MI Jing-lin,et al.Screening Key Genes Related to the Prognosis of Cervical Cancer Based on Bioinformatics Analysis[J].Medical Information,2022,35(09):8.[doi:10.3969/j.issn.1006-1959.2022.10.002]
[6]黄 花,徐冬冬,章丽霞.TGF-β1在宫颈癌中的研究进展[J].医学信息,2018,31(12):31.[doi:10.3969/j.issn.1006-1959.2018.12.011]
HUANG Hua,XU Dong-dong,ZHANG Li-xia.Research Progress of TGF-β1 in Cervical Cancer[J].Medical Information,2018,31(09):31.[doi:10.3969/j.issn.1006-1959.2018.12.011]
[7]夏易曼娜,李虎成.腹腔镜下宫颈癌根治术与传统开腹手术的对比研究[J].医学信息,2018,31(12):115.[doi:10.3969/j.issn.1006-1959.2018.12.036]
XIA Yi-manna,LI Hu-cheng.Comparative Study of Laparoscopic Radical Resection of Cervical Cancer and Traditional Open Surgery[J].Medical Information,2018,31(09):115.[doi:10.3969/j.issn.1006-1959.2018.12.036]
[8]杨 军,王翠平,李 龙,等.义安区体检HPV-DNA筛查结果分析[J].医学信息,2018,31(14):136.[doi:10.3969/j.issn.1006-1959.2018.14.041]
YANG Jun,WANG Cui-ping,LI Long,et al.Analysis of the Results of HPV-DNA Screening in the Medical Examination of Yian District[J].Medical Information,2018,31(09):136.[doi:10.3969/j.issn.1006-1959.2018.14.041]
[9]王双英,张 娜,刘 芳.具有高危复发因素的早期宫颈癌术后辅助治疗进展[J].医学信息,2018,31(15):33.[doi:10.3969/j.issn.1006-1959.2018.15.012]
WANG Shuang-ying,ZHANG Na,LIU Fang.Advances in Postoperative Adjuvant Therapy for Early Cervical Cancer with High Risk of Recurrence[J].Medical Information,2018,31(09):33.[doi:10.3969/j.issn.1006-1959.2018.15.012]
[10]聂小凤,翟慧慧,冷天艳,等.宫颈脱落细胞miR34a检测在HR-HPV阳性患者
分流中的作用分析[J].医学信息,2018,31(16):43.[doi:10.3969/j.issn.1006-1959.2018.16.012]
NIE Xiao-feng,ZHAI Hui-hui,LENG Tian-yan,et al.Analysis of the Role of MiR34a in Cervical Exfoliated Cells in Shunt of HR-HPV Positive Patients[J].Medical Information,2018,31(09):43.[doi:10.3969/j.issn.1006-1959.2018.16.012]